13F filerCIK 1536411 ↗
Duquesne Family Office
You are looking at Q4 2016. See the latest, Q3 2026 →
Reported value
$1.03B
−9.3% on the quarter before
Positions
32
19 new, 28 sold out
Top 10
62.5%
of the value
Est. gain
+$12.3M
on stocks held all quarter
Est. return
+4.2%
on those stocks since Q3 2016
Positions as of Dec 31, 2016, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.
Largest buys
Since Q3 2016, sized at quarter-end prices.
- Ishares Tr~$133.8MNew, 0.0% → 13.0% of the portfolio+991,900 shares
- Halliburton Co~$56.3MNew, 0.0% → 5.5% of the portfolio+1,041,300 shares
- Select Sector SPDR Tr~$55.7MNew, 0.0% → 5.4% of the portfolio+2,397,500 shares
- Citigroup Inc~$55.1MNew, 0.0% → 5.4% of the portfolio+927,100 shares
- Wells Fargo & Co New~$52.9MNew, 0.0% → 5.2% of the portfolio+960,400 shares
- Select Sector SPDR Tr~$51.5MNew, 0.0% → 5.0% of the portfolio+827,100 shares
- Lyondellbasell Industries N~$48.8MNew, 0.0% → 4.8% of the portfolio+568,500 shares
- Pnc Finl Svcs Group Inc~$46.4MAdded, 0.6% → 5.3% of the portfolio+396,500 shares
- Alcoa Corp~$33.7MNew, 0.0% → 3.3% of the portfolio+1,200,800 shares
- Jpmorgan Chase & Co~$28.3MNew, 0.0% → 2.8% of the portfolio+327,500 shares
Largest sells
Since Q3 2016, sized at quarter-end prices.
- Ishares Tr~$169.8MSold out, 15.0% → 0.0% of the portfolio−4,534,600 shares
- Alibaba~$49.8MSold out, 4.4% → 0.0% of the portfolio−470,600 shares
- Abbott Labs~$45.2MSold out, 4.0% → 0.0% of the portfolio−1,068,000 shares
- Broadcom Ltd~$34.8MSold out, 3.1% → 0.0% of the portfolio−201,900 shares
- Activision Blizzard Inc~$33.2MSold out, 2.9% → 0.0% of the portfolio−748,700 shares
- Barrick Gold Corp~$32.5MSold out, 2.9% → 0.0% of the portfolio−1,832,600 shares
- Amazon~$30.0MSold out, 2.7% → 0.0% of the portfolio−35,800 shares
- Agnico Eagle Mines Ltd~$28.8MSold out, 2.5% → 0.0% of the portfolio−530,800 shares
- Hdfc Bank Ltd~$27.2MSold out, 2.4% → 0.0% of the portfolio−378,600 shares
- Freeport-McMoRan~$26.3MCut, 4.7% → 3.7% of the portfolio−1,994,400 shares
Holdings
As of Dec 31, 2016; changes in shares since Sep 30, 2016.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Ishares TrRUSSELL 2000 ETF · shares New | 13.0% | $133.8M | — | ||||||
| Abbvie IncCOM · shares −7.8% · price −0.7% | 7.5% | $76.5M | −$550,342 | ||||||
| Bank Amer CorpCOM · shares +62% · price +41.2% | 5.5% | $56.6M | +$10.2M | ||||||
| Halliburton CoCOM · shares New | 5.5% | $56.3M | — | ||||||
| Select Sector SPDR TrSBI INT-FINL · shares New | 5.4% | $55.7M | — | ||||||
| Citigroup IncCOM NEW · shares New | 5.4% | $55.1M | — | ||||||
| Pnc Finl Svcs Group IncCOM · shares +571% · price +29.8% | 5.3% | $54.5M | +$1.9M | ||||||
| Wells Fargo & Co NewCOM · shares New | 5.2% | $52.9M | — | ||||||
| Select Sector SPDR TrSBI INT-INDS · shares New | 5.0% | $51.5M | — | ||||||
| Lyondellbasell Industries NSHS - A - · shares New | 4.8% | $48.8M | — | ||||||
| Merck & Co IncCOM · shares 0% · price −5.7% | 3.9% | $40.3M | −$2.4M | ||||||
| Eog Res IncCOM · shares +41% · price +4.5% | 3.8% | $38.5M | +$1.2M | ||||||
| Freeport-McMoRanCL B · shares −41% · price +21.5% | 3.7% | $38.0M | +$6.7M | ||||||
| Alcoa CorpCOM · shares New | 3.3% | $33.7M | — | ||||||
| Jpmorgan Chase & CoCOM · shares New | 2.8% | $28.3M | — | ||||||
| Nucor CorpCOM · shares +80% · price +20.4% | 2.1% | $21.5M | +$2.0M | ||||||
| Ac Immune SaSHS · shares +5.3% · price −21.2% | 2.0% | $20.5M | −$5.2M | ||||||
| Pioneer Nat Res CoCOM · shares +106% · price −3.0% | 2.0% | $20.2M | −$303,125 | ||||||
| Yahoo IncCOM · shares New | 1.8% | $18.7M | — | ||||||
| Bhp Billiton LtdSPONSORED ADR · shares 0% · price +3.3% | 1.1% | $11.6M | +$368,000 | ||||||
| Aspen Technology IncCOM · shares New | 1.1% | $11.5M | — | ||||||
| EverpureCL A · shares −53% · price −16.5% | 1.0% | $10.5M | −$2.1M | ||||||
| Transocean LtdREG SHS · shares New | 1.0% | $10.3M | — | ||||||
| Williams CompaniesCOM · shares +18% · price +1.3% | 0.99% | $10.2M | +$114,272 | ||||||
| Dover CorpCOM · shares New | 0.99% | $10.2M | — | ||||||
| Total 32 positions | 100% | $1.03B | +$12.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2016 to Q4 2016: 13 stocks held throughout, up $12.3M (+4.2%).
- Bank Amer Corp+$10.2M+41%
- Freeport-McMoRan+$6.7M+21%
- Nucor Corp+$2.0M+20%
- Pnc Finl Svcs Group Inc+$1.9M+30%
- Eog Res Inc+$1.2M+5%
- Pioneer Nat Res Co−$303,125−3%
- Abbvie Inc−$550,342−1%
- Everpure−$2.1M−17%
- Merck & Co Inc−$2.4M−6%
- Ac Immune Sa−$5.2M−21%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | $4.47B−14% | SEC ↗ |
| Q2 2026 | Aug 14, 2026 | $5.21B+54% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $3.38B−25% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $4.49B+11% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $4.06B−0% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $4.07B+33% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $3.06B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $3.72B+26% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.95B+1% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.92B−34% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $4.39B+31% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $3.35B+20% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $2.79B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $2.87B+25% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $2.31B+14% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $2.02B+15% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $1.76B+28% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.38B−40% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.31B−16% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.76B−10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $3.08B−24% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 (amended) | $4.04B−11% | SEC ↗ |
| Q1 2021 | May 17, 2021 (amended) | $4.53B+22% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.71B+8% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.44B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $3.27B+32% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.47B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $3.41B+33% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.57B−24% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.37B−2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $3.45B+100% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $1.73B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.10B+2% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.07B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.81B−9% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.98B−10% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.20B+18% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.87B+22% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.52B+49% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.03B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.13B+30% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $870.7M−35% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $1.34B | SEC ↗ |